Management of Renal Arteries in Conjunction with Thoracic Endovascular Aortic Repair for Complicated Stanford Type B Aortic Dissection: The Japanese Multicenter Study (J-Predictive Study)

Iwakoshi, Shinichi; Dake, Michael D.; Irie, Yoshihito; Katada, Yoshiaki; Sakaguchi, Shoji; Hongo, Norio; Oji, Katsuki; Fukuda, Tsuyoshi; Matsuda, Hitoshi; Kawasaki, Ryota; Taniguchi, Takanori; Motoki, Manabu; Hagihara, Makiyo; Kurimoto, Yoshihiko; Morikage, Noriyasu; Nishimaki, Hiroshi; Sueyoshi, Eijun; Inoue, Kyozo; Shimizu, Hideyuki; Ideta, Ichiro; Higashigawa, Takatoshi; Ikeda, Osamu; Miyamoto, Naokazu; Nakaï, Motoki; Nakai, Takahiro; Ichihashi, Shigeo; Inoue, Takeshi; Inoue, Takashi; Yamaguchi, Masato; Tanaka, Ryoichi; Kichikawa, Kimihiko

doi:10.1148/radiol.2020204008

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The variation in age in the two groups was large, which was related to the wide range of onset ages of aortic dissection in China (28). The majority of Chinese ATBAD patients in both groups who underwent TEVAR treatment were men, which was consistent with the current results of male dominated ATBAD epidemiological statistics (29). Most of the patients in the RAS group were overweight compared with those in the non-RAS group, but there was no significant difference between the two groups.…”

Section: Discussionsupporting

confidence: 82%

Short Term Prognosis of Renal Artery Stenosis Secondary to Acute Type B Aortic Dissection With TEVAR

Wang

et al. 2021

Front. Cardiovasc. Med.

View full text Add to dashboard Cite

Objective: To determine the effect of renal artery stenosis (RAS) resulting from acute type B aortic dissection (ATBAD) with thoracic endovascular aortic repair (TEVAR) on early prognosis in patients with ATBAD.Methods: A total of 129 ATBAD patients in the National Acute Aortic Syndrome Database (AASCN) who underwent TEVAR between 2019 and 2020 were enrolled in our study. Patients were divided into two groups: the RAS group and the non-RAS group.Results: There were 21 RAS patients (16.3%) and 108 non-RAS patients (83.7%) in our cohort. No patient in our cohort died during the 1-month follow-up. There was no significant difference in preoperative creatinine clearance rate (CCr) between the two groups (90.6 ± 46.1 μmol/L in the RAS group vs. 78.7 ± 39.2 μmol/L in the non-RAS group, P = 0.303) but the RAS group had a significantly lower estimated glomerular filtration rate (eGFR) than the non-RAS group (83.3 ± 25.0 vs. 101.9 ± 26.9 ml/min, respectively; P = 0.028).One month after TEVAR, CCr was significantly higher (99.0 ± 68.1 vs. 78.5 ± 25.8 ml/min, P = 0.043) and eGFR (81.7 ± 23.8 vs. 96.0 ± 20.0 ml/min, P = 0.017) was significantly lower in the RAS group than in the non-RAS group.Conclusions: In ATBAD, RAS could result in acute kidney injury (AKI) in the early stage after TEVAR. The RAS group had a high incidence of hypertension. These results suggest that patients with RAS may need further treatment.

show abstract

Section: Discussionsupporting

confidence: 82%

Short Term Prognosis of Renal Artery Stenosis Secondary to Acute Type B Aortic Dissection With TEVAR

Wang

et al. 2021

Front. Cardiovasc. Med.

View full text Add to dashboard Cite

show abstract

Management of Renal Arteries in Conjunction with Thoracic Endovascular Aortic Repair for Complicated Stanford Type B Aortic Dissection: The Japanese Multicenter Study (J-Predictive Study)

Cited by 1 publication

References 0 publications

Short Term Prognosis of Renal Artery Stenosis Secondary to Acute Type B Aortic Dissection With TEVAR

Short Term Prognosis of Renal Artery Stenosis Secondary to Acute Type B Aortic Dissection With TEVAR

Contact Info

Product

Resources

About